IP Library Granted Patent US 12,571,025
Granted Patent B2
US 12,571,025 · App. 18/310,276 · Granted Mar 10, 2026

Isolation and detection of DNA from plasma

Inventors: Hatim Allawi (Middleton, WI); Graham P. Lidgard (Middleton, WI); Brian Aizenstein (Madison, WI); Tamara J. Sander (Mazomanie, WI); Maria Giakoumopoulos (Middleton, WI); Michael W. Kaiser (Stoughton, WI); Melissa M. Gray (Madison, WI); Abram Michael Vaccaro (Rio, WI)
Assignee: EXACT SCIENCES CORPORATION
C12Q1/6806C12N15/1006C12Q1/6837C12Q1/686C12Q2600/154C12Q2600/166
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,571,025
App. No.
18/310,276
Granted
Mar 10, 2026
Kind
B2
Abstract

Provided herein is technology relating to the amplification-based detection of bisulfite-treated DNAs and particularly, but not exclusively, to methods and compositions for multiplex amplification of low-level sample DNA prior to further characterization of the sample DNA. The technology further provides methods for isolating DNA from blood or blood product samples, e.g., plasma samples.

Claims (29)

1 . A method of processing a sample, the method comprising:

a) combining a sample comprising nucleic acid from a human subject with:

i) a first portion of guanidine thiocyanate;

ii) a first portion of non-ionic detergent; and

iii) exogenous non-target DNA comprising bulk genomic DNA isolated from a non-human source;

to form a first mixture;

b) to the first mixture, adding:

iv) silica particles;

v) isopropyl alcohol;

vi) a second portion of guanidine thiocyanate; and

vii) a second portion of non-ionic detergent,

to form a second mixture under conditions wherein nucleic acid from said sample is bound to the silica particles; and

c) separating silica particles from the second mixture to provide separated silica particles with bound nucleic acid from the human subject.

2 . The method of claim 1 , wherein the sample is a fluid sample.

3 . The method of claim 1 , further comprising:

d) washing separated silica particles with bound nucleic acid from the human subject with a wash solution comprising alcohol.

4 . The method of claim 3 , comprising washing separated silica particles with bound nucleic acids from the human subject with a first wash solution comprising guanidine hydrochloride or guanidine thiocyanate, and ethyl alcohol.

5 . The method of claim 4 , further comprising washing separated silica particles with bound nucleic acid from the human subject with a second wash solution comprising a buffer and ethyl alcohol.

6 . The method of claim 3 , further comprising eluting nucleic acid from washed separated silica particles with bound nucleic acid from the human subject to produce eluted nucleic acid.

7 . The method of claim 1 , wherein the first portion and the second portion of non-ionic detergent are the same or different, and are selected from the group consisting of polyethylene glycol sorbitan monolaurate (Tween-20), octylphenoxypolyethoxyethanol (Nonidet P-40), and octylphenoxy poly (ethyleneoxy) ethanol, branched (IGEPAL CA-630).

8 . The method of claim 2 , wherein the fluid sample is blood or a blood product.

9 . The method of claim 8 , wherein the fluid sample is a blood product comprising plasma and/or serum.

10 . The method of claim 1 , wherein the bulk genomic DNA is from fish.

11 . The method of claim 1 , wherein the first mixture comprises a protease, and wherein proteins in the first mixture are digested by said protease.

12 . The method of claim 11 , wherein the protease comprises Proteinase K.

13 . The method of claim 6 , further comprising treating at least a portion of the eluted nucleic acid with a bisulfite reagent.

14 . The method of claim 6 , further comprising treating at least a portion of the eluted nucleic acid in an amplification reaction mixture that comprises the portion of eluted nucleic acid and amplification reagents to produce amplified DNA, wherein the portion of eluted nucleic acid used in the amplification reaction mixture has a volume and the amplification reaction mixture has a total volume, and wherein the volume of the portion of eluted nucleic acid used in the amplification reaction mixture is at least 20% of the total volume of the amplification reaction mixture.

15 . The method of claim 14 , wherein the volume of the eluted nucleic acid used in the amplification reaction mixture is at least 50% of the total volume of the amplification reaction mixture.

16 . The method of claim 14 , wherein the amplification reaction mixture comprises a buffer comprising 3-(n-morpholino) propanesulfonic acid (MOPS) buffer and 6 to 10 mM Mg ++ .

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 1, 2023
From: ALLAWI, HATIM; LIDGARD, GRAHAM P.; AIZENSTEIN, BRIAN; SANDER, TAMARA J.; GIAKOUMOPOULOS, MARIA; KAISER, MICHAEL W.; GRAY, MELISSA M.; VACCARO, ABRAM MICHAEL
To: EXACT SCIENCES CORPORATION
Reel/Frame 063496/0982 →
Continuity (4)
Continuation 17031383 · Sep 24, 2020
Continuation 15335111 · Oct 26, 2016
Provisional Application 62249097 · Oct 30, 2015
Related Publication 20230392189A1 · Dec 7, 2023
References Cited (400)
US 4376110A · David et al. · 1983 [cited by applicant]
US 4486530A · David et al. · 1984 [cited by applicant]
US 4683195A · Mullis et al. · 1987 [cited by applicant]
US 4683202A · Mullis · 1987 [cited by applicant]
US 4735214A · Berman · 1988 [cited by applicant]
US 4965188A · Mullis et al. · 1990 [cited by applicant]
US 5011769A · Duck et al. · 1991 [cited by applicant]
US 5124246A · Urdea et al. · 1992 [cited by applicant]
US 5288609A · Engelhardt et al. · 1994 [cited by applicant]
US 5338671A · Scalice et al. · 1994 [cited by applicant]
US 5403711A · Walder et al. · 1995 [cited by applicant]
US 5409818A · Davey et al. · 1995 [cited by applicant]
US 5475610A · Atwood et al. · 1995 [cited by applicant]
US 5494810A · Barany et al. · 1996 [cited by applicant]
US 5508169A · Deugau et al. · 1996 [cited by applicant]
US 5538871A · Nuovo et al. · 1996 [cited by applicant]
US 5602756A · Atwood et al. · 1997 [cited by applicant]
US 5612473A · Wu et al. · 1997 [cited by applicant]
US 5624802A · Urdea et al. · 1997 [cited by applicant]
US 5639611A · Wallace et al. · 1997 [cited by applicant]
US 5660988A · Duck et al. · 1997 [cited by applicant]
US 5710264A · Urdea et al. · 1998 [cited by applicant]
US 5773258A · Birch et al. · 1998 [cited by applicant]
US 5786146A · Herman et al. · 1998 [cited by applicant]
US 5792614A · Western et al. · 1998 [cited by applicant]
US 5846717A · Brow et al. · 1998 [cited by applicant]
US 5849481A · Urdea et al. · 1998 [cited by applicant]
US 5851770A · Babon et al. · 1998 [cited by applicant]
US 5882867A · Ullman et al. · 1999 [cited by applicant]
US 5914230A · Liu et al. · 1999 [cited by applicant]
US 5958692A · Cotton et al. · 1999 [cited by applicant]
US 5965408A · Short · 1999 [cited by applicant]
US 5985557A · Prudent et al. · 1999 [cited by applicant]
US 5994069A · Hall et al. · 1999 [cited by applicant]
US 6001567A · Brow et al. · 1999 [cited by applicant]
US 6013170A · Meade · 2000 [cited by applicant]
US 6063573A · Kayyem · 2000 [cited by applicant]
US 6090543A · Prudent et al. · 2000 [cited by applicant]
US 6110677A · Western et al. · 2000 [cited by applicant]
US 6110684A · Kemper et al. · 2000 [cited by applicant]
US 6121001A · Western et al. · 2000 [cited by applicant]
US 6150097A · Tyagi et al. · 2000 [cited by applicant]
US 6183960B1 · Lizardi · 2001 [cited by applicant]
US 6210884B1 · Lizardi · 2001 [cited by applicant]
US 6221583B1 · Kayyem et al. · 2001 [cited by applicant]
US 6235502B1 · Weissman et al. · 2001 [cited by applicant]
US 6248229B1 · Meade · 2001 [cited by applicant]
US 6251594B1 · Gonzalgo et al. · 2001 [cited by applicant]
US 6329178B1 · Patel et al. · 2001 [cited by applicant]
US 6335167B1 · Pinkel et al. · 2002 [cited by applicant]
US 6395524B2 · Loeb et al. · 2002 [cited by applicant]
US 6602695B2 · Patel et al. · 2003 [cited by applicant]
US 6605451B1 · Marmaro et al. · 2003 [cited by applicant]
US 6872816B1 · Hall et al. · 2005 [cited by applicant]
US 7037650B2 · Gonzalgo et al. · 2006 [cited by applicant]
US 7087414B2 · Gerdes et al. · 2006 [cited by applicant]
US 7122364B1 · Lyamichev et al. · 2006 [cited by applicant]
US 7256020B2 · Lyamichev et al. · 2007 [cited by applicant]
US 7662594B2 · Kong et al. · 2010 [cited by applicant]
US 7790393B2 · Lyamichev et al. · 2010 [cited by applicant]
US 8304214B2 · Gerdes et al. · 2012 [cited by applicant]
US 8361720B2 · Oldham-Haltom et al. · 2013 [cited by applicant]
US RE44596E · Stroun et al. · 2013 [cited by applicant]
US 8715937B2 · Zou et al. · 2014 [cited by applicant]
US 8808990B2 · Lidgard et al. · 2014 [cited by applicant]
US 8916344B2 · Zou et al. · 2014 [cited by applicant]
US 8962250B2 · Stanley · 2015 [cited by applicant]
US 9000146B2 · Bruinsma et al. · 2015 [cited by applicant]
US 9096893B2 · Allawi et al. · 2015 [cited by applicant]
US 9127318B2 · Oldham-Haltom et al. · 2015 [cited by applicant]
US 9163278B2 · Bruinsma et al. · 2015 [cited by applicant]
US 9169511B2 · Lidgard et al. · 2015 [cited by applicant]
US 9212392B2 · Allawi et al. · 2015 [cited by applicant]
US 9315853B2 · Domanico et al. · 2016 [cited by applicant]
US 9422592B2 · Morris et al. · 2016 [cited by applicant]
US 9428746B2 · Holmberg et al. · 2016 [cited by applicant]
US 9546403B1 · Warren et al. · 2017 [cited by applicant]
US 9637792B2 · Ahlquist et al. · 2017 [cited by applicant]
US 9657511B2 · Lidgard et al. · 2017 [cited by applicant]
US 9726670B2 · Ataman-Onal et al. · 2017 [cited by applicant]
US 9809612B2 · Ritt et al. · 2017 [cited by applicant]
US 10011878B2 · Ahlquist et al. · 2018 [cited by applicant]
US 10030272B2 · Ahlquist et al. · 2018 [cited by applicant]
US 10292687B2 · Maguire et al. · 2019 [cited by applicant]
US 10327742B2 · Fitzgerald et al. · 2019 [cited by applicant]
US 10370726B2 · Ahlquist et al. · 2019 [cited by applicant]
US 10385406B2 · Allawi et al. · 2019 [cited by applicant]
US 10435755B2 · Ahlquist et al. · 2019 [cited by applicant]
US 10465248B2 · Allawi et al. · 2019 [cited by applicant]
US 10519510B2 · Ahlquist et al. · 2019 [cited by applicant]
US 10648025B2 · Allawi et al. · 2020 [cited by applicant]
US 10648035B2 · Agarwal et al. · 2020 [cited by applicant]
US 10704081B2 · Lidgard et al. · 2020 [cited by applicant]
US 10738069B2 · Ritt et al. · 2020 [cited by applicant]
US 10822638B2 · Allawi et al. · 2020 [cited by applicant]
US 11118228B2 · Allawi et al. · 2021 [cited by applicant]
US 11345949B2 · Allawi et al. · 2022 [cited by applicant]
US 20030224040A1 · Baylin et al. · 2003 [cited by applicant]
US 20030224437A1 · Gerdes et al. · 2003 [cited by applicant]
US 20040072182A1 · Lyamichev · 2004 [cited by applicant]
US 20040175733A1 · Andersen et al. · 2004 [cited by applicant]
US 20040234960A1 · Olek et al. · 2004 [cited by applicant]
US 20050048527A1 · Allawi et al. · 2005 [cited by applicant]
US 20050214926A1 · Zielenski et al. · 2005 [cited by applicant]
US 20050239101A1 · Sukumar et al. · 2005 [cited by applicant]
US 20060134663A1 · Harkin et al. · 2006 [cited by applicant]
US 20060147955A1 · Allawi et al. · 2006 [cited by applicant]
US 20060171952A1 · Mather et al. · 2006 [cited by applicant]
US 20070048748A1 · Williams et al. · 2007 [cited by applicant]
US 20070161062A1 · Tacke et al. · 2007 [cited by applicant]
US 20070190540A1 · Stanley · 2007 [cited by applicant]
US 20070202525A1 · Quake et al. · 2007 [cited by applicant]
US 20070264659A1 · An et al. · 2007 [cited by applicant]
US 20080003571A1 · Mckernan et al. · 2008 [cited by applicant]
US 20090203011A1 · Liebenberg et al. · 2009 [cited by applicant]
US 20090253142A1 · Allawi et al. · 2009 [cited by applicant]
US 20100075334A1 · Kim et al. · 2010 [cited by applicant]
US 20110009277A1 · Devos et al. · 2011 [cited by applicant]
US 20110123990A1 · Baker et al. · 2011 [cited by applicant]
US 20110160446A1 · Ritt et al. · 2011 [cited by applicant]
US 20110217717A1 · Brody et al. · 2011 [cited by applicant]
US 20110287424A1 · Chen · 2011 [cited by applicant]
US 20110318738A1 · Jones et al. · 2011 [cited by applicant]
US 20120122088A1 · Zou et al. · 2012 [cited by applicant]
US 20120122105A1 · Oldham-Haltom et al. · 2012 [cited by applicant]
US 20120122106A1 · Zou et al. · 2012 [cited by applicant]
US 20120264618A1 · Nygren · 2012 [cited by examiner]
US 20120288868A1 · Bruinsma et al. · 2012 [cited by applicant]
US 20130022974A1 · Chinnaiyan et al. · 2013 [cited by applicant]
US 20130084287A1 · Shames et al. · 2013 [cited by applicant]
US 20130231256A1 · Oldham-Haltom et al. · 2013 [cited by applicant]
US 20130296738A1 · Swain et al. · 2013 [cited by applicant]
US 20140087382A1 · Allawi · 2014 [cited by examiner]
US 20150037802A1 · Wang · 2015 [cited by examiner]
US 20150105276A1 · Hofmann et al. · 2015 [cited by applicant]
US 20150292029A1 · Agarwal et al. · 2015 [cited by applicant]
US 20150368694A1 · Pan · 2015 [cited by examiner]
US 20150376608A1 · Kaper · 2015 [cited by examiner]
US 20160010081A1 · Allawi et al. · 2016 [cited by applicant]
US 20160017435A1 · Myers et al. · 2016 [cited by applicant]
US 20160081671A1 · Lubinski et al. · 2016 [cited by applicant]
US 20160090634A1 · Kisiel et al. · 2016 [cited by applicant]
US 20160168643A1 · Ahlquist et al. · 2016 [cited by applicant]
US 20160194721A1 · Allawi et al. · 2016 [cited by applicant]
US 20160312299A1 · Tyler et al. · 2016 [cited by applicant]
US 20160333424A1 · Morris et al. · 2016 [cited by applicant]
US 20170029808A1 · Tsukamoto · 2017 [cited by examiner]
US 20170121704A1 · Allawi et al. · 2017 [cited by applicant]
US 20170121757A1 · Lidgard et al. · 2017 [cited by applicant]
US 20170321286A1 · Allawi et al. · 2017 [cited by applicant]
US 20170335401A1 · Allawi et al. · 2017 [cited by applicant]
US 20180143198A1 · Wen et al. · 2018 [cited by applicant]
US 20180245157A1 · Allawi et al. · 2018 [cited by applicant]
US 20190085406A1 · Mortimer et al. · 2019 [cited by applicant]
US 20190177769A1 · Allawi et al. · 2019 [cited by applicant]
US 20190218601A1 · Allawi et al. · 2019 [cited by applicant]
US 20190330702A1 · Allawi et al. · 2019 [cited by applicant]
US 20200248233A1 · Allawi et al. · 2020 [cited by applicant]
US 20200291458A1 · Lidgard et al. · 2020 [cited by applicant]
US 20220071605A1 · Eisele et al. · 2022 [cited by applicant]
US 20220349009A1 · Taylor et al. · 2022 [cited by applicant]
US 20230046033A1 · Zubin et al. · 2023 [cited by applicant]
CA 2743473A1 · 2010 [cited by applicant]
CN 104781421 · 2015 [cited by applicant]
JP 2008502890 · 2008 [cited by applicant]
JP 2010533853 · 2010 [cited by applicant]
JP 2017086043A · 2017 [cited by applicant]
KR 1020160128136 · 2016 [cited by applicant]
WO WO199202258 · 1992 [cited by applicant]
WO WO199310820 · 1993 [cited by applicant]
WO WO199422892 · 1994 [cited by applicant]
WO WO199424144 · 1994 [cited by applicant]
WO WO1995000669 · 1995 [cited by applicant]
WO WO1995015373 · 1995 [cited by applicant]
WO WO1997046705 · 1997 [cited by applicant]
WO WO1999028498 · 1998 [cited by applicant]
WO WO200194634 · 2001 [cited by applicant]
WO WO2002070755 · 2002 [cited by applicant]
WO WO2005023091 · 2005 [cited by applicant]
WO WO2005038041 · 2005 [cited by applicant]
WO WO2005038051 · 2005 [cited by applicant]
WO WO2005098050 · 2005 [cited by applicant]
WO WO2005124356 · 2005 [cited by applicant]
WO WO2006084132 · 2006 [cited by applicant]
WO WO2006113770 · 2006 [cited by applicant]
WO WO2007121489 · 2007 [cited by applicant]
WO WO2008084219 · 2008 [cited by applicant]
WO WO2008100913 · 2008 [cited by applicant]
WO WO2008103763 · 2008 [cited by applicant]
WO WO2009035447 · 2009 [cited by applicant]
WO WO2009102788 · 2009 [cited by applicant]
WO WO2009146776 · 2009 [cited by applicant]
WO WO2010064702A1 · 2010 [cited by applicant]
WO WO2010074924 · 2010 [cited by applicant]
WO WO2010086389 · 2010 [cited by applicant]
WO WO2010089538 · 2010 [cited by applicant]
WO WO2011058316 · 2011 [cited by applicant]
WO WO2011119934 · 2011 [cited by applicant]
WO WO2012067831 · 2012 [cited by applicant]
WO WO2012106525A2 · 2012 [cited by applicant]
WO WO2012155072 · 2012 [cited by applicant]
WO WO2012150276A1 · 2012 [cited by applicant]
WO WO2013058868 · 2013 [cited by applicant]
WO WO2013070950 · 2013 [cited by applicant]
WO WO2013116375 · 2013 [cited by applicant]
WO WO2013142545 · 2013 [cited by applicant]
WO WO2014039556 · 2014 [cited by applicant]
WO WO2014062218 · 2014 [cited by applicant]
WO WO2014159650 · 2014 [cited by applicant]
WO WO2014159652 · 2014 [cited by applicant]
WO WO2014160117 · 2014 [cited by applicant]
WO WO2014198727A2 · 2014 [cited by applicant]
WO WO2015066695 · 2015 [cited by applicant]
WO WO2015153283 · 2015 [cited by applicant]
WO WO2015153284 · 2015 [cited by applicant]
WO WO2016094813 · 2016 [cited by applicant]
WO WO2016094839 · 2016 [cited by applicant]
WO WO2017040627 · 2017 [cited by applicant]
WO WO2017075061 · 2017 [cited by applicant]
WO WO2017129716 · 2017 [cited by applicant]
WO WO2017180886 · 2017 [cited by applicant]
WO WO2017192221 · 2017 [cited by applicant]
WO WO2017201164A1 · 2017 [cited by applicant]
WO WO2017223216 · 2017 [cited by applicant]
WO WO2018017740 · 2018 [cited by applicant]
WO WO2018045322 · 2018 [cited by applicant]
WO WO2018160576 · 2018 [cited by applicant]
WO WO2019108626 · 2019 [cited by applicant]
WO WO2020112869 · 2020 [cited by applicant]
WO WO2020154665 · 2020 [cited by applicant]
WO WO2020206256 · 2020 [cited by applicant]
WO WO2021041726 · 2021 [cited by applicant]
WO WO2021055508 · 2021 [cited by applicant]
WO WO2021076969 · 2021 [cited by applicant]
WO WO2021087275 · 2021 [cited by applicant]
WO WO2021212031 · 2021 [cited by applicant]
WO WO2021226071 · 2021 [cited by applicant]
WO WO2021226074 · 2021 [cited by applicant]
WO WO2022039904 · 2022 [cited by applicant]
WO WO2022040306 · 2022 [cited by applicant]
WO WO2022165247 · 2022 [cited by applicant]
WO WO2022187695 · 2022 [cited by applicant]
WO WO2023081796 · 2023 [cited by applicant]
Zou, et al., (2012) “Quantification of Methylated Markers with a Multiplex Methylation-Specific Technology”, Clinical Chemistry 58: 2. [cited by examiner]
Ahlquist et al., Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel. Gastroenterology, 2000;119:1219-27. [cited by applicant]
Ahlquist et al., Next-Generation Stool DNA Test Accurately Detects Colorectal Cancer and Large Adenomas. Gastroenterology, 2012;142:248-56. [cited by applicant]
Ahlquist et al., Novel Use of Hypermethylated DNA Markers in Stool for Detection of Colorectal Cancer: A Feasibility Study. Gastroenterology 2002;122:Suppl A40. [cited by applicant]
Ahlquist et al., Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia. Ann Intern Med, 2008;149(7):441-50. [cited by applicant]
Allawi et al., Abstract 712: Detection of lung cancer by assay of novel methylated DNA markers in plasma. Proceedings: AACR Annual Meeting Apr. 1-5, 2017, Washington, DC. 3 pages. [cited by applicant]
Anderson et al., Methylated DNA Markers for Detection of Sporadic Colorectal Neoplasia: Comparison Between Age Groups Younger Than and Older Than 50. Abstract Su2013. Gastroenterology Apr. 1, 2016;150(4):S-611. [cited by applicant]
Andersson et al., Properties of targeted preamplification in DNA and cDNA quantification. Expert Rev Mol Diagn. 2015;15(8):1085-100. [cited by applicant]
Antequera et al., High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. Aug. 10, 1990;62(3):503-14. [cited by applicant]
Arneson et al., GenomePlex Whole-Genome Amplification. Cold Spring Harb. Protoc. 2008; doi:10.1101/pdb.prot4920, 7 pages. [cited by applicant]
Aronchick et al., A novel tableted purgative for colonoscopic preparation: Efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointestinal endoscopy, 2000;52:346-52. [cited by applicant]
Ballabio et al., Screening for steroid sulfatase (STS) gene deletions by multiplex DNA amplification, Human Genetics, 1990, 84(6): 571-573. [cited by applicant]
Ballester et al., Novel Methylated DNA Markers for the Detection of Colorectal Neoplasia in Lynch Syndrome. Abstract 307. Gastroenterology 2016;150(4):S-70. [cited by applicant]
Barany, Genetic disease detection and DNA amplification using cloned thermostable ligase, Proc. Natl. Acad. Sci USA, 1991, 88:189-93. [cited by applicant]
Bardan et al., Colonoscopic resection of large colonic polyps—a prospective study. Israel Journal of Medical Sciences, 1997;33(12):777-80. [cited by applicant]
Belinsky et al., Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort. Cancer Res, 2006;66(6):3338-44. [cited by applicant]
Bentley et al., Accurate Whole Human Genome Sequencing using Reversible Terminator Chemistry. Nature. Nov. 6, 2008; 456(7218): 53-59. [cited by applicant]
Berezikov et al., Approaches to microRNA discovery. Nat Genet. Jun. 2006;38 Suppl:S2-7. [cited by applicant]
Berger et al., Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates. Pathology 2012;44(2):80-8. [cited by applicant]
Bibikova, GoldenGate? Assay for Methyltion of BeadArrayTM Technology. Jan. 1, 2009; retrieved from http://agtc.wayne.edu/pdfs/goldengate_methylation_brochure.pdf, retrieved Aug. 29, 2016, 7 pages. [cited by applicant]
Boynton et al., DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal Cancer. Clin Chem 2003;49(7):1058-65. [cited by applicant]
Budd et al., Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer. Clin Cancer Res. Nov. 1, 2006;12(21):6403-9. [cited by applicant]
Bustin, Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays, J. Molecular Endocrinology, 2000, 25:169-193. [cited by applicant]
Carvalho et al., Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics Chromatin. Jun. 22, 2012;5(1):9. [cited by applicant]
Certified U.S. Appl. No. 60/900,713, filed Feb. 12, 2007, in the name of Baylin et al., 188 pages. [cited by applicant]
Ceska et al., Structure-specific DNA cleavage by 5′ nucleases. Trends Biochem Sci. Sep. 1998;23(9):331-6. [cited by applicant]
Chamberlain et al., Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification, Nucleic Acids Research, 1988, 16(23):11141-11156. [cited by applicant]
Chapman et al., Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax. Mar. 2008;63(3):228-33. [cited by applicant]
Chen et al., Detection in Fecal DNA of Colon Cancer-Specific Methylation of the Nonexpressed Vimentin Gene. J Natl Cancer Inst, 2005;97:1124-32. [cited by applicant]
Chen et al., DNA Methylation Identifies Loci Distinguishing Hereditary Nonpolyposis Colorectal Cancer Without Germ-Line MLH1/MSH2 Mutation from Sporadic Colorectal Cancer. Clin Transl Gastroenterol. Dec. 15, 2016;7(12):… [cited by applicant]
Chen et al., HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer. J Pathol. Feb. 2015;235(3):397-407. [cited by applicant]
Cohen et al., Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol. Jul. 1, 2008;26(19):3213-21. [cited by applicant]
Cristofanilli et al., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. Aug. 19, 2004;351(8):781-91. [cited by applicant]
Dammann et al., The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene. Jun. 14, 2001;20(27):3563-7. [cited by applicant]
Dassonville et al., Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol. Oct. 1993;11(10):1873-8. [cited by applicant]
Devos et al., Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. Jul. 2009;55(7):1337-46. [cited by applicant]
Don et al., ‘Touchdown’ PCR to circumvent spurious priming during gene amplification, Nucleic Acids Research, 1991, 19(14):4008. [cited by applicant]
Dowdy et al., Statistics for Research, John Wiley & Sons, New York, 1983. TOC only. 6 pages. [cited by applicant]
Eads et al., CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res. May 15, 1999;59(10):2302-6. [cited by applicant]
Ebert et al., Aristaless-like Homeobox-4 Gene Methylation Is a Potential Marker for Colorectal Adenocarcinomas. Gastroenterology, 2006;131:1418-30. [cited by applicant]
Egeblad et al., New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. Mar. 2002;2(3):161-74. [cited by applicant]
Elbashir et al, RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. Jan. 15, 2001;15(2):188-200. [cited by applicant]
Fackler et al., Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res. Jul. 1, 2004;64(13):4442-52. [cited by applicant]
Fasman, “Practical Handbook of Biochemistry and Molecular Biology”, CRC Press, Boca Raton, FL. 1989, pp. 385-394. [cited by applicant]
Fedurco et al., BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies. Nucleic Acids Res. Feb. 9, 2006;34(3):e22. [cited by applicant]
Feil et al., Methylation analysis on individual chromosomes: improved protocol for bisulphite genomic sequencing. Nucleic Acids Res. Feb. 25, 1994;22(4):695-6. [cited by applicant]
Finger et al., The wonders of flap endonucleases: structure, function, mechanism and regulation. Subcell Biochem. 2012;62:301-26. [cited by applicant]
Frommer et al., A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A. Mar. 1, 1992;89(5):1827-31. [cited by applicant]
Gardiner-Garden et al., CpG Islands in Vertebrate Genomes. J. Mol. Biol. 1987:196:261-281. [cited by applicant]
Gatlin et al., Automated identification of amino acid sequence variations in proteins by HPLC/microspray tandem mass spectrometry. Anal Chem. Feb. 15, 2000;72(4):757-63. [cited by applicant]
Gemperle et al., Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages. PLoS One. 2012;7(11):e50195. 6 pages. [cited by applicant]
GenBank Accession No. NM005621. National Library of Medicine. Retrieved from the internet Sep. 29, 2022. 4 pages. [cited by applicant]
GenPept Accession No. NP05612. Sep. 11, 2022. 3 pages. [cited by applicant]
Gevaert et al., Pancancer analysis of DNA methylation-driven genes using MethylMix. Genome Biol. Jan. 29, 2015;16(1):17. 13 pages. [cited by applicant]
Gonzalgo et al., Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. Feb. 15, 1997;57(4):594-9. [cited by applicant]
Gonzalgo et al., Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res. Jun. 15, 1997;25(12):2529-31. [cited by applicant]
Grady WM, et al., Detection of Aberrantly Methylated hMLH1 Promoter DNA in the Serum of Patients with Microsatellite Unstable Colon Cancer. Cancer Res 2001;61:900-2. [cited by applicant]
Grafstrom et al., The characteristics of DNA methylation in an in vitro DNA synthesizing system from mouse fibroblasts. Nucleic Acids Res. Apr. 25, 1985;13(8):2827-42. [cited by applicant]
Grandis et al., TGF-alpha and EGFR in Head and Neck Cancer. Journal of Cellular Biochemistry, 1993; Supplement 17f:188-191. [cited by applicant]
Grigg et al., Sequencing 5-methylcytosine residues in genomic DNA. Bioessays. Jun. 1994;16(6):431-6. [cited by applicant]
Grigg, Sequencing 5-methylcytosine residues by the bisulphite method. DNA Seq. 1996;6(4):189-98. [cited by applicant]
Grunau et al., Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. Jul. 1, 2001;29(13):E65-5. 7 pages. [cited by applicant]
Gu et al., Genome-scale DNA methylation mapping of clinical samples at single-nucleotide resolution. Nat Methods. Feb. 2010;7(2):133-6. [cited by applicant]
Guilfoyle et al., Ligation-mediated PCR amplification of specific fragments from a class-II restriction endonuclease total digest, Nucleic Acids Research, 1997, 25:1854-1858. [cited by applicant]
Hall et al., Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction, PNAS, 2000, 97:8272. [cited by applicant]
Hardcastle et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996, 348:1472-7. [cited by applicant]
Harris et al., Single-molecule DNA sequencing of a viral genome. Science. Apr. 4, 2008;320(5872):106-9. [cited by applicant]
Hayden et al., Multiplex-Ready PCR: A new method for multiplexed SSR and SNP genotyping, BMC Genomics, 2008, 9:80. 12 pages. [cited by applicant]
Hayes et al., Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res. Jul. 15, 2006;12(14 Pt 1):4218-24. [cited by applicant]
Hecker et al., High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR, Biotechniques, 1996, 20(3):478-485. [cited by applicant]
Heid et al., Real time quantitative PCR . Genome Res. Oct. 1996;6(10):986-94. [cited by applicant]
Heitman et al., Colorectal Cancer Screening for Average-Risk North Americans: An Economic Evaluation. PLoS Med, 2010;7(11):e1000370. 13 pages. [cited by applicant]
Heller et al., Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev. Mar. 2010;29(1):95-107. [cited by applicant]
Henegariu et al., Multiplex PCR: critical parameters and step-by-step protocol. Biotechniques. Sep. 1997;23(3):504-11. [cited by applicant]
Heresbach, D., et al., Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006, 18(4):427-33. [cited by applicant]
Herman et al., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826. [cited by applicant]
Higuchi et al., A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions, Nucleic Acids Research, 1988, 16(15):7351-7367. [cited by applicant]
Higuchi et al., Simultaneous amplification and detection of specific DNA sequences, Biotechnology, 1992, 10:413-417. [cited by applicant]
Higuchi et al.,Kinetic PCR analysis: real-time monitoring of DNA amplification reactions, Biotechnology, 1993, 11:1026-1030. [cited by applicant]
Hoque et al., Genome-Wide Promoter Analysis Uncovers Portions of the Cancer Methylome. J Clin Oncol. 2005;23:6569-75. [cited by applicant]
Hua et al., Quantitative methylation analysis of multiple genes using methylation-sensitive restriction enzyme-based quantitative PCR for the detection of hepatocellular carcinoma. Exp Mol Pathol. Aug. 2011;91(1):455-60. [cited by applicant]
Huang et al., Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res. Jun. 15, 2007;67(12):5906-13. [cited by applicant]
Imperiale et al., Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population. N Engl J Med, 2004;351:2704-14. [cited by applicant]
Iqbal et al., Safety and efficacy of a minimally invasive cell sampling device (‘Cytosponge’) in the diagnosis of esophageal pathology: a systematic review. Eur J Gastroenterol Hepatol. Nov. 2018;30(11):1261-1269. [cited by applicant]
Itzkowitz et al., Improved Fecal DNA Test for Colorectal Cancer Screening. Clin Gastroenterol Hepatol 2007;5(1):111-7. [cited by applicant]
Iyer et al., Accurate nonendoscopic detection of Barrett's esophagus by methylated DNA Markers: A multisite case control study. Am J Gastroenterol 2020;115:1201-1209. [cited by applicant]
Iyer et al., Accurate non-endoscopic detection of Barrett's esophagus in a multicenter prospective validation cohort: the sos 2 trial. AGA Abstracts. 2018:878. S-175-S-176. [cited by applicant]
Iyer et al., Independent validation of an accurate methylated DNA marker panel for the non-endoscopic detection of Barrett's esophagus: a multisite case control study. AGA Abstracts. 2020; 1084: S-211. [cited by applicant]
Jiang et al., Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A. Mar. 17, 2015;112(11):E1317-25. [cited by applicant]
Jongeneel et al., An atlas of human gene expression from massively parallel signature sequencing (MPSS) Genome Res. Jul. 2005;15(7):1007-14. [cited by applicant]
Kaiser et al., A comparison of eubacterial and archaeal structure-specific 5′- exonucleases. J Biol Chem. Jul. 23, 1999;274(30):21387-94. [cited by applicant]
Kalinina et al., Nanoliter scale PCR with TaqMan detection, Nucleic Acids Research, 1997, 25:1999-2004. [cited by applicant]
Kann et al., Improved Marker Combination for Detection of De Novo Genetic Variation and Aberrant DNA in Colorectal Neoplasia. Clin Chem 2006;52:2299-302. [cited by applicant]
Karl et al., Improved Diagnosis of Colorectal Cancer Using a Combination of Fecal Occult Blood and Novel Fecal Protein Markers. Clin Gastroenterol Hepatol, 2008;6(10):1122-8. [cited by applicant]
Kawai et al., Comparison of DNA methylation patterns among mouse cell lines by restriction landmark genomic scanning. Mol Cell Biol. Nov. 1994;14(11):7421-7. [cited by applicant]
Kisiel et al., New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clin Cancer Res. Oct. 1, 2015;21(19):4473-81. [cited by applicant]
Kisiel et al., Novel Stool DNA Markers for Inflammatory Bowel Disease Asociated Colorectal Cancer High Grade Dysplasia: High Specificity Across Three Independent International Poplulations. Abstract 185. Gatroenterology… [cited by applicant]
Kling. Ultrafast DNA sequencing. Nat Biotechnol. Dec. 2003;21(12):1425-7. [cited by applicant]
Kneip et al., SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol. Oct. 2011;6(10):1632-8. [cited by applicant]
Knute et al., MicroRNAs as Novel Targets for NSAID Chemoprevention of Color Carcinogenesis. Gastroenterology. May 2011; 140(5):S-41. [cited by applicant]
Kober et al., Methyl-CpG binding column-based identification of nine genes hypermethylated in colorectal cancer. Mol Carcinog. Nov. 2011;50(11):846-56. [cited by applicant]
Korbie et al., Multiplex bisulfite PCR resequencing of clinical FFPE DNA. Clin Epigenetics. Mar. 17, 2015;7:28. [cited by applicant]
Kronborg et al., Randomized Study of Biennial Screening with a Faecal Occult Blood Test: Results After Nine Screening Rounds. Scand J Gastroenterol, 2004; 39:846-51. [cited by applicant]
Kuppuswamy et al., Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes. Proc Natl Acad Sci U S A. Feb. 15, 1991;88(4):1143-7. [cited by applicant]
Lange et al., Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One. 2012;7(11):e50266. 10 pages. [cited by applicant]
Leontiou et al., Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing. PLoS One.… [cited by applicant]
Leung et al., Detection of Epigenetic Changes in Fecal DNA as a Molecular Screening Test for Colorectal Cancer: A Feasibility Study. Clin Chem, 2004;50(11):2179-82. [cited by applicant]
Levin et al., Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. Mar. 2017;62(3):678-688. [cited by applicant]
Levin et al., Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cance… [cited by applicant]
Liu et al., Flap endonuclease 1: a central component of DNA metabolism. Annu Rev Biochem. 2004;73:589-615. [cited by applicant]
Lokk et al., Methylation markers of early-stage non-small cell lung cancer. PLoS One. 2012;7(6):e39813. 9 pages. [cited by applicant]
Louwagie et al., Feasibility of a DNA methylation assay for noninvasive CRC screening. Clin Cancer Res. Oct. 2007;13(19 Suppl):B16. 4 pages. [cited by applicant]
Lyamichev et al.,Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes, Nat. Biotech., 1999, 17:292-296. [cited by applicant]
Mandal et al., Lipopolysaccharide induces formyl peptide receptor 1 gene expression in macrophages and neutrophils via transcriptional and posttranscriptional mechanisms. J Immunol. Nov. 1, 2005;175(9):6085-91. [cited by applicant]
Mandal et al., Signaling in lipopolysaccharide-induced stabilization of formyl peptide receptor 1 mRNA in mouse peritoneal macrophages. J Immunol. Feb. 15, 2007;178(4):2542-8. [cited by applicant]
Mandel et al., Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood. N Engl J Med. 1993, 328:1365-71. [cited by applicant]
Marabella et al., Serum ribonuclease in patients with lung carcinoma. J Surg Oncol. 1976;8(6):501-5. [cited by applicant]
Margulies et al., Genome sequencing in microfabricated high-density picolitre reactors. Nature. Sep. 15, 2005;437(7057):376-80. [cited by applicant]
Martin et al., Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines. Gene. May 19, 1995;157(1-2):261-4. [cited by applicant]
Maxwell® RSC ccfDNA Plasma Kit, Technical Manual, Instructions for Use of Product AS1480, Promega Corporation, Feb. 2016. 8 pages. [cited by applicant]
Medina-Aguilar et al., Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol. PLoS One. Jun. 29, 2016;11(6):e0157866. 20 pages. [cited by applicant]
Meissner et al., Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United States. Cancer Epidemiol Biomarkers Prev., 2006; 15:389-94. [cited by applicant]
Meissner et al., Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. Oct. 13, 2005;33(18):5868-77. [cited by applicant]
Melnikov et al., MSRE-PCR for analysis of gene-specific DNA methylation. Nucleic Acids Res. Jun. 8, 2005;33(10):e93. [cited by applicant]
Mitchell et al., A panel of genes methylated with high frequency in colorectal cancer. BMC Cancer. Jan. 31, 2014;14:54. 15 pages. [cited by applicant]
Mitchell et al., Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer. Genes (Basel). Dec. 15, 2016;7(12):125. 11 pages. [cited by applicant]
Monte et al., Cloning, chromosome mapping and functional characterization of a human homologue of murine gtse-1 (B99) gene. Gene. Aug. 22, 2000;254(1-2):229-36. [cited by applicant]
Monte et al., hGTSE-1 expression stimulates cytoplasmic localization of p53. J Biol Chem. Mar. 19, 2004;279(12):11744-52. [cited by applicant]
Moon et al., Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer. J Exp Clin Cancer Res. 2014;33:4. 10 pages. [cited by applicant]
Moreno et al., Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. Apr. 2005;65(4):713-8. [cited by applicant]
Morris et al., Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer. Int J Cancer. Jun. 1, 2018;142(11):2355-2362. [cited by applicant]
Muller et al., Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet, 2004;363:1283-5. [cited by applicant]
Munson et al., Recovery of bisulfite-converted genomic sequences in the methylation-sensitive QPCR. Nucleic Acids Res. 2007;35(9):2893-903. [cited by applicant]
NCBI Ref. Seq. NM_001193306.1. Apr. 9, 2019. Retrieved from NIH Sep. 29, 2022. 5 pages. [cited by applicant]
Neuwelt et al., Possible sites of origin of human plasma ribonucleases as evidenced by isolation and partial characterization of ribonucleases from several human tissues. Cancer Res. Jan. 1978;38(1):88-93. [cited by applicant]
Nilsson et al., Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes. Diabetes. Sep. 2014;63:2962-76. [cited by applicant]
Notice of Opposition and Statement filed in EP Pat 3434791, filed Mar. 5, 2021, 16 pages. [cited by applicant]
Noutsias et al., Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Molecular Biology Jan. 14, 2008;9:3. 20 pages. [cited by applicant]
Nyce et al. Variable effects of DNA-synthesis inhibitors upon DNA methylation in mammalian cells. Nucleic Acids Res. 1986;14: 4353-4367. [cited by applicant]
O'Driscoll et al., Feasibility and relevance of global expression profiling of gene transcripts in serum from breast cancer patients using whole genome microarrays and quantitative RT-PCR. Cancer Genomics Proteomics. Ma… [cited by applicant]
Olek et al., A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res. Dec. 15, 1996;24(24):5064-6. [cited by applicant]
Olek et al., The pre-implantation ontogeny of the H19 methylation imprint. Nat Genet. Nov. 1997;17(3):275-6. [cited by applicant]
Olivier, The Invader assay for SNP genotyping, Mutat Res. Jun. 3, 2005;573(1-2):103-10. [cited by applicant]
Olkhov-Mitsel et al., Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. Sci Rep. Mar. 21, 2014;4:4432. [cited by applicant]
Ooki et al., Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer. Oncogene. Jun. 3, 2010;29(22):3263-75. [cited by applicant]
Orpana, Fluorescence resonance energy transfer (FRET) using ssDNA binding fluorescent dye, Biomol Eng. Apr. 2004;21(2):45-50. [cited by applicant]
Osborn et al. Stool screening for colorectal cancer: Molecular approaches. Gastroenterology, 2005;128(1):192-206. [cited by applicant]
Osman et al., Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells. Immunology. Jan. 2002;105(1):73-82. [cited by applicant]
Pantel et al., Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. May 2008;8(5):329-40. [cited by applicant]
Parekh et al., As tests evolve and costs of cancer care rise: reappraising stool-based screening for colorectal neoplasia. Aliment Pharmacol Ther 2008;27:697-712. [cited by applicant]
Petko et al., Aberrantly Methylated CDKN2A, MGMT, and MLH1 in Colon Polyps and in Fecal DNA from Patients with Colorectal Polyps. Clin Cancer Res, 2005;11:1203-9. [cited by applicant]
Ponomaryova et al., Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients. Lung Cancer. Sep. 2013;81(3):397-403. [cited by applicant]
Ramsahoye et al., Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci U S A. May 9, 2000;97(10):5237-42. [cited by applicant]
Reddi et al., Elevated serum ribonuclease in patients with pancreatic cancer. Proc Natl Acad Sci U S A. Jul. 1976;73(7):2308-10. [cited by applicant]
Rein et al., Identifying 5-methylcytosine and related modifications in DNA genomes. Nucleic Acids Res. May 15, 1998;26(10):2255-64. [cited by applicant]
Reinartz et al., Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organisms. Brief Funct Genomic Proteomic. Feb. 2002;1(1):95-104. [cited by applicant]
Rex et al., American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol, 2009;104:739-50. [cited by applicant]